Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) dropped 9% during mid-day trading on Thursday . The company traded as low as GBX 1.32 and last traded at GBX 1.32. Approximately 101,585 shares traded hands during mid-day trading, a decline of 79% from the average daily volume of 475,768 shares. The stock had previously closed at GBX 1.45.
Cizzle Biotechnology Stock Up 2.8%
The firm has a 50-day simple moving average of GBX 1.55 and a 200 day simple moving average of GBX 1.54. The company has a market cap of £5.91 million, a price-to-earnings ratio of -4.66 and a beta of 0.38.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
See Also
- Five stocks we like better than Cizzle Biotechnology
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
